Dahu Aquaculture Co.,Ltd. (SHSE:600257) agreed to acquire additional 32% stake in Dongfang Huakang Medical Management Co., Ltd from a group of sellers for CNY 200 million on April 14, 2020. Under the terms, Kafu Health Technology (Shanghai) Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Jiang Baolong will receive CNY 86.4 million, CNY 58.4 million, CNY 49.6 million and CNY 5.6 million respectively. The payment will be done in two installments. First payment will be done within 7 days since signing of the agreement. The second installment will comprise the rest of the compensation and will be payable before October 30, 2020. As of May 29, 2020, Kafu Health Technology (Shanghai) Co., Ltd, Shanghai Zhuoying Medical Management Partnership (Limited Partnership), Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership), Jiang Baolong, B6 Li Aichuan and Dahu Aquaculture hold 42.96%, 16.02%, 17.36%, 9%, 1.78%, 4.88% and 8% stake in Dongfang Huakang Medical Management respectively. Post completion, Kafu Health Technology (Shanghai) Co., Ltd, Shanghai Zhuoying Medical Management Partnership (Limited Partnership), Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership), Jiang Baolong, B6 Li Aichuan and Dahu Aquaculture will hold 19.03%, 5.8%, 5.35%, 5.38%, 0.79%, 3.65% and 60% stake in Dongfang Huakang Medical Management respectively. In a related private placement transaction, Dahu Aquaculture Co.,Ltd. will invest CNY 125 million in Dongfang Huakang Medical Management Co., Ltd. As of December 31, 2019, Dongfang Huakang Medical Management reported total assets of CNY 182.8 million, net assets of CNY 130.25 million, revenue of CNY 87.69 million and net loss of CNY 26.61 million. The transaction is subject to Dahu Aquaculture's shareholder approval. The transaction was approved by the Board of Directors of Dahu Aquaculture on the 21st meeting of the 7th directorate held on April 14, 2020. As on May 29, 2020, the transaction was further approved by the independent directors at 24th meeting of 7th board of directors and 19th meeting of the 7th board of supervisors. As on June 15, 2020, the transaction has been approved by the shareholders of Dahu Aquaculture.